Detalhe da pesquisa
1.
Utility of a physiologically-based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug-drug-disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practice.
Biopharm Drug Dispos
; 33(2): 99-110, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22270945
2.
Eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.
Oncology (Williston Park)
; 23(13): 1171-7, 2009 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-20043468
3.
Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.
Oncology (Williston Park)
; 23(8): 704-9, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19711585
4.
FDA report: eculizumab (Soliris) for the treatment of patients with paroxysmal nocturnal hemoglobinuria.
Oncologist
; 13(9): 993-1000, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18784156
5.
Deferasirox for the treatment of chronic iron overload in transfusional hemosiderosis.
Oncology (Williston Park)
; 20(14): 1799-1806, 1811; discussion 1811-13, 1817, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17263129
6.
Safety of ximelagatran.
JAMA
; 293(23): 2859; author reply 2859-60, 2005 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15956625